Accordingly, both technologies reported the overexpression of STIM1, MBP, SEPTIN9, and SEPTIN10 and the downregulation of CRACR2A, ORMDL3, SARAF, SEPTIN3, and SEPTIN6 in colon cancer cells. Here, SEPTIN3 is linked to colonic neoplasm.